Copyright Reports & Markets. All rights reserved.

Global Selpercatinib Capsules Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Specification
    • 1.3.1 Overview: Global Selpercatinib Capsules Consumption Value by Specification: 2021 Versus 2025 Versus 2032
    • 1.3.2 40mg
    • 1.3.3 80mg
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Selpercatinib Capsules Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Non-Small Cell Lung Cancer (NSCLC)
    • 1.4.3 Thyroid Carcinoma
    • 1.4.4 Others
  • 1.5 Global Selpercatinib Capsules Market Size & Forecast
    • 1.5.1 Global Selpercatinib Capsules Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Selpercatinib Capsules Sales Quantity (2021-2032)
    • 1.5.3 Global Selpercatinib Capsules Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Eli Lilly
    • 2.1.1 Eli Lilly Details
    • 2.1.2 Eli Lilly Major Business
    • 2.1.3 Eli Lilly Selpercatinib Capsules Product and Services
    • 2.1.4 Eli Lilly Selpercatinib Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Eli Lilly Recent Developments/Updates
  • 2.2 Innovnent Biologics
    • 2.2.1 Innovnent Biologics Details
    • 2.2.2 Innovnent Biologics Major Business
    • 2.2.3 Innovnent Biologics Selpercatinib Capsules Product and Services
    • 2.2.4 Innovnent Biologics Selpercatinib Capsules Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Innovnent Biologics Recent Developments/Updates

3 Competitive Environment: Selpercatinib Capsules by Manufacturer

  • 3.1 Global Selpercatinib Capsules Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Selpercatinib Capsules Revenue by Manufacturer (2021-2026)
  • 3.3 Global Selpercatinib Capsules Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Selpercatinib Capsules by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Selpercatinib Capsules Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Selpercatinib Capsules Manufacturer Market Share in 2025
  • 3.5 Selpercatinib Capsules Market: Overall Company Footprint Analysis
    • 3.5.1 Selpercatinib Capsules Market: Region Footprint
    • 3.5.2 Selpercatinib Capsules Market: Company Product Type Footprint
    • 3.5.3 Selpercatinib Capsules Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Selpercatinib Capsules Market Size by Region
    • 4.1.1 Global Selpercatinib Capsules Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Selpercatinib Capsules Consumption Value by Region (2021-2032)
    • 4.1.3 Global Selpercatinib Capsules Average Price by Region (2021-2032)
  • 4.2 North America Selpercatinib Capsules Consumption Value (2021-2032)
  • 4.3 Europe Selpercatinib Capsules Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Selpercatinib Capsules Consumption Value (2021-2032)
  • 4.5 South America Selpercatinib Capsules Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Selpercatinib Capsules Consumption Value (2021-2032)

5 Market Segment by Specification

  • 5.1 Global Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 5.2 Global Selpercatinib Capsules Consumption Value by Specification (2021-2032)
  • 5.3 Global Selpercatinib Capsules Average Price by Specification (2021-2032)

6 Market Segment by Application

  • 6.1 Global Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 6.2 Global Selpercatinib Capsules Consumption Value by Application (2021-2032)
  • 6.3 Global Selpercatinib Capsules Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 7.2 North America Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 7.3 North America Selpercatinib Capsules Market Size by Country
    • 7.3.1 North America Selpercatinib Capsules Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Selpercatinib Capsules Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 8.2 Europe Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 8.3 Europe Selpercatinib Capsules Market Size by Country
    • 8.3.1 Europe Selpercatinib Capsules Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Selpercatinib Capsules Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 9.2 Asia-Pacific Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Selpercatinib Capsules Market Size by Region
    • 9.3.1 Asia-Pacific Selpercatinib Capsules Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Selpercatinib Capsules Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 10.2 South America Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 10.3 South America Selpercatinib Capsules Market Size by Country
    • 10.3.1 South America Selpercatinib Capsules Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Selpercatinib Capsules Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Selpercatinib Capsules Sales Quantity by Specification (2021-2032)
  • 11.2 Middle East & Africa Selpercatinib Capsules Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Selpercatinib Capsules Market Size by Country
    • 11.3.1 Middle East & Africa Selpercatinib Capsules Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Selpercatinib Capsules Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Selpercatinib Capsules Market Drivers
  • 12.2 Selpercatinib Capsules Market Restraints
  • 12.3 Selpercatinib Capsules Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Selpercatinib Capsules and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Selpercatinib Capsules
  • 13.3 Selpercatinib Capsules Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Selpercatinib Capsules Typical Distributors
  • 14.3 Selpercatinib Capsules Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Selpercatinib Capsules market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Selpercatinib, sold under the brand name Retevmo among others, is a medication for the treatment of cancers in people whose tumors have an alteration (mutation or fusion) in a specific gene. This medication is used to treat certain types of cancer (such as lung cancer, thyroid cancer, medullary thyroid cancer, certain other solid tumors).
    This report is a detailed and comprehensive analysis for global Selpercatinib Capsules market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Specification and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Selpercatinib Capsules market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Selpercatinib Capsules market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Selpercatinib Capsules market size and forecasts, by Specification and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Selpercatinib Capsules market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Selpercatinib Capsules
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Selpercatinib Capsules market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Eli Lilly, Innovnent Biologics, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Selpercatinib Capsules market is split by Specification and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Specification, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Specification
    40mg
    80mg
    Market segment by Application
    Non-Small Cell Lung Cancer (NSCLC)
    Thyroid Carcinoma
    Others
    Major players covered
    Eli Lilly
    Innovnent Biologics
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Selpercatinib Capsules product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Selpercatinib Capsules, with price, sales quantity, revenue, and global market share of Selpercatinib Capsules from 2021 to 2026.
    Chapter 3, the Selpercatinib Capsules competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Selpercatinib Capsules breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Specification and by Application, with sales market share and growth rate by Specification, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Selpercatinib Capsules market forecast, by regions, by Specification, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Selpercatinib Capsules.
    Chapter 14 and 15, to describe Selpercatinib Capsules sales channel, distributors, customers, research findings and conclusion.

    Buy now